Ozon A - Search Results

1

Alterations in insulin-like growth factor system in spinal muscular atrophy.

Kaymaz AY, Bal SK, Bora G, Talim B, Ozon A, Alikasifoglu A, Topaloglu H, Yurter HE. Kaymaz AY, et al. Among authors: ozon a. Muscle Nerve. 2022 Nov;66(5):631-638. doi: 10.1002/mus.27715. Epub 2022 Sep 15. Muscle Nerve. 2022. PMID: 36050898

2

Iodine deficiency in Turkey.

Yordam N, Ozön A, Alikaşifoğlu A, Ozgen A, Ceren N, Zafer Y, Simşek E. Yordam N, et al. Among authors: ozon a. Eur J Pediatr. 1999 Jun;158(6):501-5. doi: 10.1007/s004310051130. Eur J Pediatr. 1999. PMID: 10378401

3

Type 1 diabetes mellitus in a 3 1/2 year-old girl with Turner's syndrome.

Gonc EN, Ozon A, Alikasifoglu A, Kandemir N. Gonc EN, et al. Among authors: ozon a. J Pediatr Endocrinol Metab. 2002 Sep-Oct;15(8):1203-6. doi: 10.1515/jpem.2002.15.8.1203. J Pediatr Endocrinol Metab. 2002. PMID: 12387520

4

Serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 levels in severe iodine deficiency.

Alikaşifoğlu A, Ozön A, Yordam N. Alikaşifoğlu A, et al. Among authors: ozon a. Turk J Pediatr. 2002 Jul-Sep;44(3):215-8. Turk J Pediatr. 2002. PMID: 12405432

5

Endocrinological outcome of different treatment options in children with craniopharyngioma: a retrospective analysis of 66 cases.

Gonc EN, Yordam N, Ozon A, Alikasifoglu A, Kandemir N. Gonc EN, et al. Among authors: ozon a. Pediatr Neurosurg. 2004 May-Jun;40(3):112-9. doi: 10.1159/000079852. Pediatr Neurosurg. 2004. PMID: 15367800

6

Influence of iodine supplementation on serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) levels in severe iodine deficiency.

Ozön A, Alikaşifoğlu A, Yordam N. Ozön A, et al. Turk J Pediatr. 2004 Oct-Dec;46(4):303-8. Turk J Pediatr. 2004. PMID: 15641262 Clinical Trial.

7

Ten-year experience in management of diabetic ketoacidosis and ketosis: 140 episodes at pediatric age.

Yordam N, Gönç EN, Kandemir N, Alikaşifoğlu A, Ozön A. Yordam N, et al. Among authors: ozon a. Turk J Pediatr. 2005 Oct-Dec;47(4):334-8. Turk J Pediatr. 2005. PMID: 16363342

8

Thrombin-activatable fibrinolysis inhibitor activity and global fibrinolytic capacity in Type 1 diabetes: evidence for normal fibrinolytic state.

Harmanci A, Kandemir N, Dagdelen S, Gonc N, Buyukasik Y, Alikasifoglu A, Kirazli S, Ozon A, Gurlek A. Harmanci A, et al. Among authors: ozon a. J Diabetes Complications. 2006 Jan-Feb;20(1):40-4. doi: 10.1016/j.jdiacomp.2005.05.003. J Diabetes Complications. 2006. PMID: 16389166

9

Inappropriate use of potent topical glucocorticoids in infants.

Ozon A, Cetinkaya S, Alikasifoglu A, Gonc EN, Sen Y, Kandemir N. Ozon A, et al. J Pediatr Endocrinol Metab. 2007 Feb;20(2):219-25. doi: 10.1515/jpem.2007.20.2.219. J Pediatr Endocrinol Metab. 2007. PMID: 17396439

10

Hashimoto's thyroiditis in children and adolescents: a retrospective study on clinical, epidemiological and laboratory properties of the disease.

Demirbilek H, Kandemir N, Gonc EN, Ozon A, Alikasifoglu A, Yordam N. Demirbilek H, et al. Among authors: ozon a. J Pediatr Endocrinol Metab. 2007 Nov;20(11):1199-205. doi: 10.1515/jpem.2007.20.11.1199. J Pediatr Endocrinol Metab. 2007. PMID: 18183791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters